Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 532

    1.

    Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): Rationale and study design.

    Shikata K, Haneda M, Koya D, Suzuki Y, Tomino Y, Yamada K, Maeda S, Kawakami N, Uzu T, Nishimura M, Sato C, Ogawa D, Makino H; DNETT-Japan Study Group.

    Diabetes Res Clin Pract. 2009 Nov 2. [Epub ahead of print]PMID: 19889469 [PubMed - as supplied by publisher]Related articles

    2.

    Clinicoepidemiological manifestations of RPGN and ANCA-associated vasculitides: an 11-year retrospective hospital-based study in Japan.

    Suzuki Y, Takeda Y, Sato D, Kanaguchi Y, Tanaka Y, Kobayashi S, Suzuki K, Hashimoto H, Ozaki S, Horikoshi S, Tomino Y.

    Mod Rheumatol. 2009 Oct 10. [Epub ahead of print]PMID: 19821007 [PubMed - as supplied by publisher]Related articles

    3.

    Beneficial effects of combination therapy with olmesartan and azelnidipine in murine polycystic kidneys.

    Tanifuji C, Suzuki Y, Geot WM, Horikoshi S, Takahashi H, Tomino Y.

    Kidney Blood Press Res. 2009;32(4):239-49. Epub 2009 Sep 14.PMID: 19752573 [PubMed - in process]Related articles

    4.

    A novel measurement method for activation of the lectin complement pathway via both mannose-binding lectin (MBL) and L-ficolin.

    Inoshita H, Matsushita M, Koide S, Kusaba G, Ishii M, Onda K, Gi MJ, Nakata M, Ohsawa I, Horikoshi S, Ohi H, Tomino Y.

    J Immunol Methods. 2009 Sep 30;349(1-2):9-17. Epub 2009 Aug 20.PMID: 19699205 [PubMed - indexed for MEDLINE]Related articles

    5.

    Long-term effect of modification of dietary protein intake on the progression of diabetic nephropathy: a randomised controlled trial.

    Koya D, Haneda M, Inomata S, Suzuki Y, Suzuki D, Makino H, Shikata K, Murakami Y, Tomino Y, Yamada K, Araki SI, Kashiwagi A, Kikkawa R; Low-Protein Diet Study Group.

    Diabetologia. 2009 Oct;52(10):2037-45. Epub 2009 Aug 4.PMID: 19652945 [PubMed - in process]Related articlesFree article

    6.

    Combination effects of enalapril and losartan on lipid peroxidation in the kidneys of KK-Ay/Ta mice.

    Yamazaki T, Tanimoto M, Gohda T, Ohara I, Hagiwara S, Murakoshi M, Matsumoto M, Kaneko S, Aoki T, Toyoda H, Ishikawa Y, Funabiki K, Horikoshi S, Tomino Y.

    Nephron Exp Nephrol. 2009;113(2):e66-76. Epub 2009 Jul 16.PMID: 19609084 [PubMed - in process]Related articles

    7.

    The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification.

    Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H.

    Kidney Int. 2009 Sep;76(5):534-45. Epub 2009 Jul 1.PMID: 19571791 [PubMed - indexed for MEDLINE]Related articles

    8.

    The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility.

    Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D'Agati V, D'Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H.

    Kidney Int. 2009 Sep;76(5):546-56. Epub 2009 Jul 1.PMID: 19571790 [PubMed - indexed for MEDLINE]Related articles

    9.

    Alterations in proteoglycan components and histopathology of the peritoneum in uraemic and peritoneal dialysis (PD) patients.

    Osada S, Hamada C, Shimaoka T, Kaneko K, Horikoshi S, Tomino Y.

    Nephrol Dial Transplant. 2009 Nov;24(11):3504-12. Epub 2009 Jun 19.PMID: 19542195 [PubMed - in process]Related articles

    10.

    Contribution of subcutaneous fat accumulation to insulin resistance and atherosclerosis in haemodialysis patients.

    Gotoh H, Gohda T, Tanimoto M, Gotoh Y, Horikoshi S, Tomino Y.

    Nephrol Dial Transplant. 2009 Nov;24(11):3474-80. Epub 2009 Jun 17.PMID: 19535435 [PubMed - in process]Related articles

    11.

    A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity.

    Koyama A, Yamagata K, Makino H, Arimura Y, Wada T, Nitta K, Nihei H, Muso E, Taguma Y, Shigematsu H, Sakai H, Tomino Y, Matsuo S; Japan RPGN Registry Group.

    Clin Exp Nephrol. 2009 Jun 17. [Epub ahead of print]PMID: 19533266 [PubMed - as supplied by publisher]Related articles

    12.

    A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study.

    Goto M, Wakai K, Kawamura T, Ando M, Endoh M, Tomino Y.

    Nephrol Dial Transplant. 2009 Oct;24(10):3068-74. Epub 2009 Jun 10.PMID: 19515800 [PubMed - in process]Related articlesFree article

    13.

    Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.

    Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J.

    J Clin Invest. 2009 Jun;119(6):1668-77. doi: 10.1172/JCI38468. Epub 2009 May 26.PMID: 19478457 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy.

    Miura N, Imai H, Kikuchi S, Hayashi S, Endoh M, Kawamura T, Tomino Y, Moriwaki K, Kiyomoto H, Kohagura K, Nakazawa E, Kusano E, Mochizuki T, Nomura S, Sasaki T, Kashihara N, Soma J, Tomo T, Nakabayashi I, Yoshida M, Watanabe T.

    Clin Exp Nephrol. 2009 Oct;13(5):460-6. Epub 2009 May 19.PMID: 19449181 [PubMed - in process]Related articles

    15.

    Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice.

    Hagiwara S, Gohda T, Tanimoto M, Ito T, Murakoshi M, Ohara I, Yamazaki T, Matsumoto M, Horikoshi S, Funabiki K, Tomino Y.

    Metabolism. 2009 Jul;58(7):934-45.PMID: 19427656 [PubMed - indexed for MEDLINE]Related articles

    16.

    Antiproteinuric effect of olmesartan in patients with IgA nephropathy.

    Tomino Y, Kawamura T, Kimura K, Endoh M, Hosoya T, Horikoshi S, Utsunomiya Y, Yasuda T, Toyoda M, Tsuge T, Kaneko K.

    J Nephrol. 2009 Mar-Apr;22(2):224-31. Erratum in: J Nephrol. 2009 May-Jun;22(3):421. PMID: 19384840 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Anti-GBM glomerulonephritis and RPGN]

    Shimizu Y, Tomino Y.

    Nippon Jinzo Gakkai Shi. 2009;51(2):94-7. Review. Japanese. No abstract available. PMID: 19378793 [PubMed - indexed for MEDLINE]Related articles

    18.

    Revised equations for estimated GFR from serum creatinine in Japan.

    Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A; Collaborators developing the Japanese equation for estimated GFR.

    Am J Kidney Dis. 2009 Jun;53(6):982-92. Epub 2009 Apr 1.PMID: 19339088 [PubMed - indexed for MEDLINE]Related articles

    19.

    Report of the Asian Forum of Chronic Kidney Disease Initiative (AFCKDI) 2007. "Current status and perspective of CKD in Asia": diversity and specificity among Asian countries.

    Tsukamoto Y, Wang H, Becker G, Chen HC, Han DS, Harris D, Imai E, Jha V, Li PK, Lee EJ, Matsuo S, Tomino Y, Tungsanga K, Yamagata K, Hishida A.

    Clin Exp Nephrol. 2009 Jun;13(3):249-56. Epub 2009 Mar 14.PMID: 19288169 [PubMed - indexed for MEDLINE]Related articles

    20.

    Long-term effects of the oral adsorbent, AST-120, in patients with chronic renal failure.

    Maeda K, Hamada C, Hayashi T, Shou I, Wakabayashi M, Fukui M, Horikoshi S, Tomino Y.

    J Int Med Res. 2009 Jan-Feb;37(1):205-13.PMID: 19215692 [PubMed - indexed for MEDLINE]Related articles

    21.

    Pleiotropic effect of pyridoxamine on diabetic complications via CD36 expression in KK-Ay/Ta mice.

    Murakoshi M, Tanimoto M, Gohda T, Hagiwara S, Ohara I, Toyoda H, Ishikawa Y, Horikoshi S, Tomino Y.

    Diabetes Res Clin Pract. 2009 Feb;83(2):183-9. Epub 2009 Jan 13.PMID: 19144436 [PubMed - indexed for MEDLINE]Related articles

    22.

    Tubular epithelial cells have the capacity to transdifferentiate into CD68-positive macrophage-like cells by oxidative stress.

    Tanaka M, Suzuki Y, Shirato I, Takahara H, Shibata T, Sugaya T, Shimamoto K, Horikoshi S, Tomino Y.

    Inflamm Res. 2008 Dec;57(12):593-600.PMID: 19109740 [PubMed - indexed for MEDLINE]Related articles

    23.

    Risk stratification for progression of IgA nephropathy using a decision tree induction algorithm.

    Goto M, Kawamura T, Wakai K, Ando M, Endoh M, Tomino Y.

    Nephrol Dial Transplant. 2009 Apr;24(4):1242-7. Epub 2008 Nov 17.PMID: 19017674 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Acute renal failure in a patient with severe malaria and dengue shock syndrome.

    Thaha M, Pranawa, Yogiantoro M, Tanimoto M, Tomino Y.

    Clin Nephrol. 2008 Nov;70(5):427-30.PMID: 19000545 [PubMed - indexed for MEDLINE]Related articles

    25.

    Association of endothelial nitric oxide synthase Glu298Asp polymorphism with end-stage renal disease.

    Thaha M, Pranawa, Yogiantoro M, Sutjipto, Sunarjo, Tanimoto M, Gohda T, Tomino Y.

    Clin Nephrol. 2008 Aug;70(2):144-54.PMID: 18793530 [PubMed - indexed for MEDLINE]Related articles

    26.

    Toll-like receptor 9 affects severity of IgA nephropathy.

    Suzuki H, Suzuki Y, Narita I, Aizawa M, Kihara M, Yamanaka T, Kanou T, Tsukaguchi H, Novak J, Horikoshi S, Tomino Y.

    J Am Soc Nephrol. 2008 Dec;19(12):2384-95. Epub 2008 Sep 5.PMID: 18776126 [PubMed - indexed for MEDLINE]Related articles

    27.

    [Regulation of actin cytoskeleton in renal podocytes]

    Asanuma K, Tomino Y.

    Nippon Jinzo Gakkai Shi. 2008;50(5):532-9. Review. Japanese. No abstract available. PMID: 18767478 [PubMed - indexed for MEDLINE]Related articles

    28.

    Progression of a sessile serrated adenoma to an early invasive cancer within 8 months.

    Oono Y, Fu K, Nakamura H, Iriguchi Y, Yamamura A, Tomino Y, Oda J, Mizutani M, Takayanagi S, Kishi D, Shinohara T, Yamada K, Matumoto J, Imamura K.

    Dig Dis Sci. 2009 Apr;54(4):906-9. Epub 2008 Aug 8.PMID: 18688718 [PubMed - indexed for MEDLINE]Related articles

    29.

    IgA nephropathy: lessons from an animal model, the ddY mouse.

    Tomino Y.

    J Nephrol. 2008 Jul-Aug;21(4):463-7. Review.PMID: 18651534 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    T cell cytokine polarity as a determinant of immunoglobulin A (IgA) glycosylation and the severity of experimental IgA nephropathy.

    Chintalacharuvu SR, Yamashita M, Bagheri N, Blanchard TG, Nedrud JG, Lamm ME, Tomino Y, Emancipator SN.

    Clin Exp Immunol. 2008 Sep;153(3):456-62. Epub 2008 Jul 11.PMID: 18637102 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function.

    Gohda T, Tanimoto M, Moon JY, Gotoh H, Aoki T, Matsumoto M, Shibata T, Ohsawa I, Funabiki K, Tomino Y.

    Diabetes Res Clin Pract. 2008 Aug;81(2):196-201. Epub 2008 Jun 11.PMID: 18550199 [PubMed - indexed for MEDLINE]Related articles

    32.

    [Pathogenesis of IgA nephropathy: current understanding of mucosa-bone marrow axis in IgA nephropathy]

    Suzuki Y, Suzuki H, Tomino Y.

    Nippon Jinzo Gakkai Shi. 2008;50(4):456-60. Review. Japanese. No abstract available. PMID: 18546874 [PubMed - indexed for MEDLINE]Related articles

    33.

    [Overview of IgA nephropathy]

    Tomino Y.

    Nippon Jinzo Gakkai Shi. 2008;50(4):440-1. Japanese. No abstract available. PMID: 18546871 [PubMed - indexed for MEDLINE]Related articles

    34.

    Effect of pitavastatin on type 2 diabetes mellitus nephropathy in KK-Ay/Ta mice.

    Matsumoto M, Tanimoto M, Gohda T, Aoki T, Murakoshi M, Yamada K, Yamazaki T, Kaneko S, Horikoshi S, Tomino Y.

    Metabolism. 2008 May;57(5):691-7.PMID: 18442635 [PubMed - indexed for MEDLINE]Related articles

    35.

    Renal pathology of ANCA-related vasculitis: proposal for standardization of pathological diagnosis in Japan.

    Joh K, Muso E, Shigematsu H, Nose M, Nagata M, Arimura Y, Yumura W, Wada T, Nitta K, Makino H, Taguma Y, Kaneoka H, Suzuki Y, Kobayashi M, Koyama A, Usui J, Hashimoto H, Ozaki S, Tomino Y, Yamagata K.

    Clin Exp Nephrol. 2008 Aug;12(4):277-91. Epub 2008 Apr 22. Review.PMID: 18425690 [PubMed - indexed for MEDLINE]Related articles

    37.

    Relationship between abdominal fat accumulation and insulin resistance in hemodialysis patients.

    Gohda T, Gotoh H, Tanimoto M, Sato M, Io H, Kaneko K, Hamada C, Tomino Y.

    Hypertens Res. 2008 Jan;31(1):83-8.PMID: 18360022 [PubMed - indexed for MEDLINE]Related articles

    38.

    Prediction of diagnosis of immunoglobulin A nephropathy prior to renal biopsy and correlation with urinary sediment findings and prognostic grading.

    Nakayama K, Ohsawa I, Maeda-Ohtani A, Murakoshi M, Horikoshi S, Tomino Y.

    J Clin Lab Anal. 2008;22(2):114-8.PMID: 18348316 [PubMed - indexed for MEDLINE]Related articles

    39.

    Amelioration of crescentic glomerulonephritis by RhoA kinase inhibitor, Fasudil, through podocyte protection and prevention of leukocyte migration.

    Hidaka T, Suzuki Y, Yamashita M, Shibata T, Tanaka Y, Horikoshi S, Tomino Y.

    Am J Pathol. 2008 Mar;172(3):603-14. Epub 2008 Feb 2.PMID: 18245810 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Intravenous N-acetylcysteine during hemodialysis reduces asymmetric dimethylarginine level in end-stage renal disease patients.

    Thaha M, Widodo, Pranawa W, Yogiantoro M, Tomino Y.

    Clin Nephrol. 2008 Jan;69(1):24-32.PMID: 18226399 [PubMed - indexed for MEDLINE]Related articles

    41.

    Potential immunopathogenic role of the mucosa-bone marrow axis in IgA nephropathy: insights from animal models.

    Suzuki Y, Tomino Y.

    Semin Nephrol. 2008 Jan;28(1):66-77.PMID: 18222348 [PubMed - indexed for MEDLINE]Related articles

    42.

    Pathogenesis and treatment of type 2 diabetic nephropathy: lessons from the spontaneous KK/Ta mouse model.

    Tomino Y, Tanimoto M, Shike T, Shiina K, Fan Q, Liao J, Gohda T, Makita Y, Funabiki K.

    Curr Diabetes Rev. 2005 Aug;1(3):281-6. Review.PMID: 18220604 [PubMed - indexed for MEDLINE]Related articles

    43.

    Improvement of peritoneal calcification after parathyroidectomy in a peritoneal dialysis patient.

    Inoshita H, Gohda T, Io H, Kaneko K, Hamada C, Horikoshi S, Tomino Y.

    Clin Nephrol. 2008 Jan;69(1):58-62.PMID: 18218318 [PubMed - indexed for MEDLINE]Related articles

    44.

    Effect of educational hospitalization on chronic kidney disease (CKD) patients.

    Yamaji K, Kurusu A, Okamoto M, Sekiguchi Y, Horikoshi S, Tomino Y.

    Clin Nephrol. 2007 Dec;68(6):401-4.PMID: 18184523 [PubMed - indexed for MEDLINE]Related articles

    45.

    Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia--changes in serum potassium levels with or without a RAAS inhibitor.

    Tomino Y, Yamazaki T, Shou I, Tsuge T, Satake K, Takeda Y, Ohtani A, Nishitani T, Kurusu A, Hamada C, Horikoshi S, Maeda K, Tanaka Y, Fukuda H, Wakabayashi M, Seto T.

    Clin Nephrol. 2007 Dec;68(6):379-85.PMID: 18184520 [PubMed - indexed for MEDLINE]Related articles

    46.

    IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.

    Suzuki H, Moldoveanu Z, Hall S, Brown R, Vu HL, Novak L, Julian BA, Tomana M, Wyatt RJ, Edberg JC, Alarcón GS, Kimberly RP, Tomino Y, Mestecky J, Novak J.

    J Clin Invest. 2008 Feb;118(2):629-39.PMID: 18172551 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Peritubular ischemia contributes more to tubular damage than proteinuria in immune-mediated glomerulonephritis.

    Wong MG, Suzuki Y, Tanifuji C, Akiba H, Okumura K, Sugaya T, Yamamoto T, Horikoshi S, Tan SY, Pollock C, Tomino Y.

    J Am Soc Nephrol. 2008 Feb;19(2):290-7. Epub 2007 Dec 19. No abstract available. PMID: 18094368 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Peritoneal fibrosis intervention.

    Kaneko K, Hamada C, Tomino Y.

    Perit Dial Int. 2007 Jun;27 Suppl 2:S82-6. Review.PMID: 17556336 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Possible involvement of mast cells in renal fibrosis in patients with IgA nephropathy.

    Sakamoto-Ihara T, Suzuki Y, Kurusu A, Yamashita M, Horikoshi S, Tomino Y.

    Inflamm Res. 2007 Oct;56(10):421-7.PMID: 18026699 [PubMed - indexed for MEDLINE]Related articles

    50.

    The role of podocytes in proteinuria.

    Asanuma K, Yanagida-Asanuma E, Takagi M, Kodama F, Tomino Y.

    Nephrology (Carlton). 2007 Dec;12 Suppl 3:S15-20. Review.PMID: 17995522 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...